| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ELITE PHARMACEUTICALS INC /NV/ | CEO, President, Director, 10%+ Owner | Common Stock | 217M | $7.91M | $0.04 | 29 Mar 2024 | Direct |
| ELITE PHARMACEUTICALS INC /NV/ | CEO, President, Director, 10%+ Owner | Common Stock | 2.7M | $98.6K | $0.04 | 29 Mar 2024 | by IRA |
| ELITE PHARMACEUTICALS INC /NV/ | CEO, President, Director, 10%+ Owner | Common Stock | 2.22M | $81.1K | $0.04 | 29 Mar 2024 | by Kristine Hakim |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ELTP | ELITE PHARMACEUTICALS INC /NV/ | 29 Mar 2024 | 1 | $0 | 4 | CEO, President, Director, 10%+ Owner | 02 Apr 2024, 16:58 |
| ELTP | ELITE PHARMACEUTICALS INC /NV/ | 29 Dec 2023 | 0 | $0 | 4/A | CEO & President, Director, 10%+ Owner | 02 Apr 2024, 16:56 |
| ELTP | ELITE PHARMACEUTICALS INC /NV/ | 29 Dec 2023 | 1 | $153K | 4 | CEO, President, Director, 10%+ Owner | 29 Dec 2023, 14:21 |